Transformative Diagnostics


Next-Generation Therapies & Vaccines

Addressing large, unmet global markets with innovative proprietary products More »


Worldwide Production & Distribution

Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »


Strategic Investments

Identifying early-stage companies with potential to increase value for shareholders More »

Chairman’s Message

read more »

OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors and I would like to review several highlights.

News & Events

more news »

OPKO Announces Second Quarter Operating and Financial Results more »

Rayaldee Phase 3 Trial Meets Primary Endpoints more »

OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy more »


read more »

OPKO Health is an opportunistic research and development company that targets large, high-growth markets.